{
  "objective": {
    "answer": "The primary objective of the paper is to experimentally test the application of large language models, specifically GPT4, as a source of scientific hypotheses in the domain of breast cancer treatment. The authors aimed to determine whether GPT4 could generate novel, effective drug combinations for targeting breast cancer cell lines, and to validate these hypotheses through laboratory experiments.",
    "evidence": "Here, we experimentally test the application of LLMs as a source of scientific hypotheses using the domain of breast cancer treatment. We applied the LLM GPT4 to hypothesize novel synergistic pairs of US Food and Drug Administration (FDA)-approved non-cancer drugs that target the MCF7 breast cancer cell line relative to the non-tumorigenic breast cell line MCF10A."
  },
  "knowledge_gap": {
    "answer": "The utility of large language models for generating scientific hypotheses, particularly in drug discovery and cancer treatment, has been little investigated, despite their potential to go beyond existing text-based tools.",
    "evidence": "Despite the clear potential of LLMs for hypothesis generation, their utility for hypothesis generation has been little investigated."
  },
  "novelty": {
    "answer": [
      "First experimental validation of large language model-generated scientific hypotheses in the context of breast cancer drug discovery.",
      "Application of GPT4 to generate novel, synergistic drug combinations using only non-cancer, FDA-approved drugs for breast cancer cell lines.",
      "Iterative use of laboratory results to refine and improve large language model-generated hypotheses.",
      "Direct comparison of outputs from multiple large language models (GPT4, Gemini, PubMedGPT) for scientific hypothesis generation."
    ],
    "evidence": [
      "Here, we experimentally test the application of LLMs as a source of scientific hypotheses using the domain of breast cancer treatment.",
      "We prompted ChatGPT4 to propose hypotheses relating to novel drug combinations for targeted breast cancer treatment, specifically towards the MCF7 breast cancer cell line.",
      "GPT4 then generated new combinations based on its initial results, this generated three more combinations with positive synergy scores (out of four tested).",
      "We compared the outputs from GPT4, Gemini and the specialized LLM PubMedGPT. The results revealed both similarities and notable differences in the selected drugs and their subsequent combinations (electronic supplementary material, appendix C)."
    ]
  },
  "inspirational_papers": {
    "answer": [
      "King RD et al. (2009) The automation of science. Science 324, 85–89. (Methodological precursors)",
      "Popper K. (1972) The logic of scientific discovery. London, UK: Hutchinson. (Methodological precursors)"
    ],
    "evidence": [
      "17. King RD et al. 2009 The automation of science. Science 324, 85–89. (doi:10.1126/science.1165620)",
      "18. Popper K. 1972 The logic of scientific discovery. London, UK: Hutchinson."
    ]
  },
  "method": {
    "steps": [
      {
        "step": "Prompt GPT4 to generate hypotheses for novel drug combinations targeting the MCF7 breast cancer cell line while sparing the MCF10A non-tumorigenic cell line.",
        "input": "Prompt text specifying requirements for drug combinations (e.g., at least one non-antineoplastic drug, FDA-approved, affordable, accessible).",
        "output": "A list of hypothesized drug pairs with mechanistic rationales.",
        "tools": [
          "GPT4: A large language model used to generate drug combination hypotheses."
        ],
        "evidence": "We prompted ChatGPT4 to propose hypotheses relating to novel drug combinations for targeted breast cancer treatment, specifically towards the MCF7 breast cancer cell line."
      },
      {
        "step": "Select and screen the generated drug combinations in laboratory experiments using MCF7 and MCF10A cell lines.",
        "input": "Drug pairs generated by GPT4; MCF7 and MCF10A cell cultures.",
        "output": "Experimental data on cell viability and drug synergy for each combination.",
        "tools": [
          "Laboratory automation: Used to test drug combinations on cell lines."
        ],
        "evidence": "These are the hypotheses that we experimentally tested using laboratory automation."
      },
      {
        "step": "Analyze the additivity and synergy of drug combinations using SynergyFinder 3.0.",
        "input": "Experimental dose-response data from cell viability assays.",
        "output": "HSA (Highest Single Agent) synergy scores for each drug combination.",
        "tools": [
          "SynergyFinder 3.0: Software for calculating drug synergy scores."
        ],
        "evidence": "To determine drug additivities/synergies, we employed SynergyFinder 3.0 to calculate HSA synergy scores for all combinations (table 2)."
      },
      {
        "step": "Iteratively refine hypotheses by providing GPT4 with experimental results and prompting for new or improved drug combinations.",
        "input": "Summary of experimental results from previous rounds.",
        "output": "New or refined drug combination hypotheses.",
        "tools": [
          "GPT4: Used again for iterative hypothesis generation based on feedback."
        ],
        "evidence": "We provided GPT4 with a summary of the results from the primary screen (electronic supplementary material, figure S4) and prompted GPT4 to consider combinations containing drugs from the positive controls as well."
      }
    ],
    "tools": [
      "GPT4: Large language model used for generating drug combination hypotheses and explanations.",
      "Laboratory automation: Used for high-throughput screening of drug combinations on cell lines.",
      "SynergyFinder 3.0: Software tool for calculating drug synergy and additivity scores from experimental data."
    ],
    "evidence": [
      "We prompted ChatGPT4 to propose hypotheses relating to novel drug combinations for targeted breast cancer treatment, specifically towards the MCF7 breast cancer cell line.",
      "These are the hypotheses that we experimentally tested using laboratory automation.",
      "To determine drug additivities/synergies, we employed SynergyFinder 3.0 to calculate HSA synergy scores for all combinations (table 2)."
    ]
  },
  "subject_area": {
    "areas": [
      "Health Sciences",
      "Biological Sciences",
      "Chemical Sciences"
    ],
    "evidence": [
      "We chose breast cancer as our test domain due to its critical importance in medical research, the vast body of existing literature, and our access to specialized equipment for studying tissue cultures as proxies for real patient tumours.",
      "Treatment options for breast cancer include various drug therapies.",
      "We prompted ChatGPT4 to propose hypotheses relating to novel drug combinations for targeted breast cancer treatment, specifically towards the MCF7 breast cancer cell line."
    ]
  },
  "performance_summary": {
    "performance_summary": [
      "In the first round of laboratory experiments, GPT4 succeeded in discovering three drug combinations (out of 12 tested) with synergy scores above the positive controls.",
      "In the second iteration, GPT4 generated new combinations based on initial results, resulting in three more combinations with positive synergy scores (out of four tested).",
      "Several combinations showed higher specificity and synergy for the MCF7 cancer cell line compared to the MCF10A control."
    ],
    "baselines": [
      "Positive controls: doxorubicin + cyclophosphamide and fulvestrant + palbociclib, both FDA-approved combinations for breast cancer treatment.",
      "Negative controls: allopurinol + omeprazole and diphenhydramine + cetirizine, combinations unlikely to affect MCF7 cells."
    ],
    "benchmark_datasets": [
      "Not reported in the paper. The study used laboratory-generated data from MCF7 and MCF10A cell lines rather than established benchmark datasets."
    ],
    "evaluation_metrics": [
      "HSA (Highest Single Agent) synergy score: Measures whether the effect of a drug combination is greater than that of the most effective single agent.",
      "IC50 values: Concentration of drug required to inhibit cell viability by 50%, used to assess toxicity and specificity.",
      "ANOVA two-way test: Used to calculate the significance of changes to viability compared with internal controls."
    ],
    "evidence": [
      "In the first round of laboratory experiments, GPT4 succeeded in discovering three drug combinations (out of 12 tested) with synergy scores above the positive controls. GPT4 then generated new combinations based on its initial results, this generated three more combinations with positive synergy scores (out of four tested).",
      "In addition to hypothesizing drug combinations, we prompted GPT4 to provide two positive controls that are commonly used against breast cancer in clinics and likely have an impact on MCF7, as well as two negative control combinations that would be unlikely to cause harm to MCF7 (electronic supplementary material, figures S2 and S3).",
      "To determine drug additivities/synergies, we employed SynergyFinder 3.0 to calculate HSA synergy scores for all combinations (table 2).",
      "IC50 values could only be calculated for 5/11 compounds (electronic supplementary material, table S8), disulfiram and doxorubicin showing submicromolar IC50 values of 0.059 and 0.3 µM, respectively.",
      "An ANOVA two-way test with three replicates was used to calculate the significance of changes to viability compared with the internal control drug allopurinol for both cell lines (electronic supplementary material, figures S6 and S7)."
    ]
  },
  "limitations": {
    "limitations": [
      {
        "label": "Unclear Model Understanding",
        "explanation": "It is unclear to what extent GPT4 understood its prompt for hypothesis formation, leading to epistemological uncertainty in the generated hypotheses.",
        "evidence": "It is unclear to what extent GPT4 ‘understood’ its prompt for hypothesis formation. This epistemological uncertainty is shown in the relationship between the explanation of why a pair of drugs would target MCF7 rather than MCF10A (electronic supplementary material, table S1), and the explanation why MCF10A would not be targeted, where the MCF10A hypotheses are simply negations of the MCF7 ones."
      },
      {
        "label": "Biological Inconsistencies",
        "explanation": "Some of GPT4's explanations for drug mechanisms were biologically flawed, indicating a lack of deep biological knowledge.",
        "evidence": "LLMs’ outputs are not necessarily consistent with known biological knowledge. Some of ChatGPT4’s explanations for hypotheses were biologically flawed. This is most clearly illustrated by GPT4’s hypothesis that itraconazole would ‘disrupt(ing) cell membrane integrity’. This explanation presumably originated from the fact that itraconazole inhibits ergosterol synthesis, which disrupts cell membrane integrity. The factual error is that ergosterol synthesis is not present in mammalian cells."
      },
      {
        "label": "Lack of Curated Data Use",
        "explanation": "The study did not investigate whether using curated literature or datasets would improve hypothesis quality.",
        "evidence": "One avenue for future investigation is whether using curated literature and/or datasets as opposed to the whole Internet improves the quality of hypotheses."
      }
    ],
    "evidence": [
      "It is unclear to what extent GPT4 ‘understood’ its prompt for hypothesis formation. This epistemological uncertainty is shown in the relationship between the explanation of why a pair of drugs would target MCF7 rather than MCF10A (electronic supplementary material, table S1), and the explanation why MCF10A would not be targeted, where the MCF10A hypotheses are simply negations of the MCF7 ones.",
      "LLMs’ outputs are not necessarily consistent with known biological knowledge. Some of ChatGPT4’s explanations for hypotheses were biologically flawed. This is most clearly illustrated by GPT4’s hypothesis that itraconazole would ‘disrupt(ing) cell membrane integrity’. This explanation presumably originated from the fact that itraconazole inhibits ergosterol synthesis, which disrupts cell membrane integrity. The factual error is that ergosterol synthesis is not present in mammalian cells.",
      "One avenue for future investigation is whether using curated literature and/or datasets as opposed to the whole Internet improves the quality of hypotheses."
    ]
  },
  "future_directions": {
    "future_directions": [
      "Investigate whether using curated literature and/or datasets, as opposed to the whole Internet, improves the quality of large language model-generated hypotheses.",
      "Analyze pair frequency distributions per large language model to better understand the diversity and consistency of drug suggestions.",
      "Explore the variability of outcomes produced by different large language models and how such variability might be exploited for scientific discovery."
    ],
    "evidence": [
      "One avenue for future investigation is whether using curated literature and/or datasets as opposed to the whole Internet improves the quality of hypotheses.",
      "In future studies, it may be useful to analyse pair frequency distributions per LLM.",
      "It is outside of the scope of this study to analyse the variability of such outcomes. Instead, we consider how such variability might be exploited to aid scientists in uncovering new cancer treatments."
    ]
  },
  "resource_link": {
    "answer": "https://doi.org/10.6084/m9.figshare.c.7837896",
    "evidence": "Electronic supplementary material is available online at https://doi.org/10.6084/m9.figshare.c.7837896."
  },
  "paper_title": "Scientific hypothesis generation by large language models: laboratory validation in breast cancer treatment",
  "authors": [
    "Abbi",
    "Hector",
    "Oghenejokpeme",
    "Marie",
    "Ross J.",
    "Elizabeth",
    "Gareth W.",
    "Emma",
    "Holly X.",
    "Larisa N.",
    "Ross"
  ],
  "published": "06/2025",
  "link": "https://royalsocietypublishing.org/doi/10.1098/rsif.2024.0674"
}